| Drug Repurposing for Candidate SARS-CoV-2 Main Protease Inhibitors by a Novel In Silico Method M Sencanski, V Perovic, SB Pajovic, M Adzic, S Paessler, S Glisic Molecules 25 (17), 3830, 2020 | 65 | 2020 |
| A comparison of various variational approaches for solving the one-dimensional vibrational Schrödinger equation R Vujasin, M Sencanski, J Radic-Peric, M Peric MATCH Commun. Math. Comput. Chem 63 (2), 363-378, 2010 | 63 | 2010 |
| Zn (II) complex with 2-quinolinecarboxaldehyde selenosemicarbazone: synthesis, structure, interaction studies with DNA/HSA, molecular docking and caspase-8 and-9 independent … NR Filipović, S Bjelogrlić, A Marinković, TŽ Verbić, IN Cvijetić, ... RSC advances 5 (115), 95191-95211, 2015 | 37 | 2015 |
| Arginase Flavonoid Anti-Leishmanial in Silico Inhibitors Flagged against Anti-Targets S Glisic, M Sencanski, V Perovic, S Stevanovic, AT García-Sosa Molecules 21 (5), 589, 2016 | 31 | 2016 |
| Natural products as promising therapeutics for treatment of influenza disease M Sencanski, D Radosevic, V Perovic, B Gemovic, M Stanojevic, ... Current pharmaceutical design 21 (38), 5573-5588, 2015 | 30 | 2015 |
| Dynamics of the water molecules at the intrinsic liquid surface as seen from molecular dynamics simulation and identification of truly interfacial molecules analysis B Fabian, MV Senćanski, IN Cvijetic, P Jedlovszky, G Horvai The Journal of Physical Chemistry C 120 (16), 8578-8588, 2016 | 27 | 2016 |
| Pd (II) complexes with N-heteroaromatic hydrazone ligands: Anticancer activity, in silico and experimental target identification SK Bjelogrlić, TR Todorović, M Kojić, M Senćanski, M Nikolić, A Višnjevac, ... Journal of inorganic biochemistry 199, 110758, 2019 | 25 | 2019 |
| In silico analysis suggests interaction between Ebola virus and the extracellular matrix V Veljkovic, S Glisic, CP Muller, M Scotch, DR Branch, VR Perovic, ... Frontiers in microbiology 6, 130551, 2015 | 24 | 2015 |
| Synthesis, in silico, and in vitro evaluation of anti-leishmanial activity of oxadiazoles and indolizine containing compounds flagged against anti-targets S Stevanovic, M Sencanski, M Danel, C Menendez, R Belguedj, ... Molecules 24 (7), 1282, 2019 | 23 | 2019 |
| In Silico Discovery of a Substituted 6-Methoxy-quinalidine with Leishmanicidal Activity in Leishmania infantum S Stevanović, A Perdih, M Senćanski, S Glišić, M Duarte, AM Tomas, ... Molecules 23 (4), 772, 2018 | 23 | 2018 |
| In silico analysis suggests repurposing of ibuprofen for prevention and treatment of EBOLA virus disease V Veljkovic, M Goeijenbier, S Glisic, N Veljkovic, VR Perovic, M Sencanski, ... F1000Research 4, 2015 | 23 | 2015 |
| Novel electrophilic amides amenable by the Ugi reaction perturb thioredoxin system via thioredoxin reductase 1 (TrxR1) inhibition: Identification of DVD-445 as a new lead … M Jovanović, D Zhukovsky, A Podolski-Renić, I Domračeva, ... European Journal of Medicinal Chemistry 181, 111580, 2019 | 21 | 2019 |
| Virtual screen for repurposing of drugs for candidate influenza a M2 ion-channel inhibitors D Radosevic, M Sencanski, V Perovic, N Veljkovic, J Prljic, V Veljkovic, ... Frontiers in Cellular and Infection Microbiology 9, 67, 2019 | 21 | 2019 |
| Ibuprofen as a template molecule for drug design against Ebola virus S Paessler, C Huang, M Sencanski, N Veljkovic, V Perovic, S Glisic, ... Front Biosci (Landmark Ed) 23, 947-53, 2018 | 20 | 2018 |
| Ni (II) complex with bishydrazone ligand: synthesis, characterization, DNA binding studies and pro-apoptotic and pro-differentiation induction in human cancerous cell lines NR Filipović, S Bjelogrlić, TR Todorović, VA Blagojević, CD Muller, ... RSC advances 6 (110), 108726-108740, 2016 | 17 | 2016 |
| Molecular Modeling of 5HT2A Receptor – Arylpiperazine Ligands Interactions M Sencanski, V Sukalovic, K Shakib, V Soskic, L Dosen‐Micovic, ... Chemical Biology & Drug Design 83 (4), 462-471, 2014 | 17 | 2014 |
| Critical impact of different conserved endoplasmic retention motifs and dopamine receptor interacting proteins (DRIPs) on intracellular localization and trafficking of the D2 … K Blagotinšek Cokan, M Mavri, CS Rutland, S Glišić, M Senćanski, ... Biomolecules 10 (10), 1355, 2020 | 16 | 2020 |
| Biological rationale for the repurposing of BCG vaccine against SARS-CoV-2 S Glisic, VR Perovic, M Sencanski, S Paessler, V Veljkovic Journal of Proteome Research 19 (11), 4649-4654, 2020 | 15 | 2020 |
| Determination of key receptor–ligand interactions of dopaminergic arylpiperazines and the dopamine D2 receptor homology model V Sukalovic, V Soskic, M Sencanski, D Andric, S Kostic-Rajacic Journal of molecular modeling 19, 1751-1762, 2013 | 15 | 2013 |
| Pro-apoptotic and pro-differentiation induction by 8-quinolinecarboxaldehyde selenosemicarbazone and its Co (III) complex in human cancer cell lines NR Filipović, S Bjelogrlić, G Portalone, S Pelliccia, R Silvestri, O Klisurić, ... MedChemComm 7 (8), 1604-1616, 2016 | 14 | 2016 |
